Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r1_c1.jpg

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c1.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c2.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c4.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c5.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c8.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c11.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c12.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c14.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c16.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c18.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r2_c20.jpg

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r3_c2.jpg

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c2.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c3.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c6.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c7.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c9.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c10.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c13.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c15.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c17.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c19.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r4_c21.jpg

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r5_c3.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r5_c7.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r5_c10.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r5_c15.jpg

Description: C:\Users\Danny Kwong\Desktop\images\menu_H_r5_c19.jpg

Description: C:\Users\Danny Kwong\Desktop\images\spacer.gif

Portfolio Companies

Tools:

Alpha Innotech, , Biocompare, Epitomics, Fermentas, Genewiz, Panomics, SuperArray Biosciences, System Biosciences

Drug Development:

BioKey, Optimer Pharmaceuticals, StemCyte, TP Therapeutics

Diagnostics:

Advanced Cell Diagnostics, Diagcor, Diagnostic Hybrids (DHI),

Medical Devices

BioForm

Other:

 

Description: C:\Users\Danny Kwong\Desktop\images\alphainnotech.gif

Alpha Innotech
www.alphainnotech.com
San Leandro, California
Alpha Innotech is providing complete imaging solutions for the genetic research and drug discovery markets.  The company was acquired by Cell Biosciences in Santa Clara, California in October 2009.

Advanced Cell Diagnostics, Inc.

http://www.acdbio.com

Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine.   ACD’s products and services are based on its proprietary RNAscope® Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.  The company was acquired by Bio-Techne (NASDAQ: TECH) in August, 2016.

 

Apexigen, Inc.

www.apexigen.com

Burlingame, California

Apexigen™ is a biopharmaceutical product development company pioneering the next generation of antibody drugs. With the use of proprietary platform technology based on humanized rabbit-derived antibodies, the company seeks to aid in the discovery and development of better treatments for serious and difficult to treat diseases.

 

Description: C:\Users\Danny Kwong\Desktop\images\bioform.gif

BioForm Mediacl, Inc.
www.bioform.com
San Mateo, California
BioForm Medical, Inc. (NASDAQ: BFRM) is a medical device company developing and commercializing a family of proprietary injectable implant products for the treatment of certain illness as well as for the use in cosmetic tissue augmentation.  The company went public in November 2007.

Description: C:\Users\Danny Kwong\Desktop\images\biokey.gif

BioKey, Inc.
www.biokeyinc.com
Fremont, California
BioKey is using controlled release platform technologies to develop and market generic drugs and accelerated new drug application (NDA) products.

Description: C:\Users\Danny Kwong\Desktop\images\DiagCor_Logo.jpg

DiagCor Bioscience Inc. Limited
www.diagcor.com
Hong Kong, PRC
Diagcor develops and commercializes in vitro diagnostic kits and instrumentations using company's proprietary platform technology.  Moreover, DiagCor utilizes its forefront expertise to build the genomic testing diagnostic service network in Mainland China and Asia Pacific Region.

Description: C:\Users\Danny Kwong\Desktop\images\dhi.gif

Diagnostic Hybrids, Inc.
www.dhiusa.com
Athens, Ohio
Diagnostic Hybrids develops, manufactures, and markets diagnostic cell cultures and virus detection kit systems used in the clinical diagnosis of infectious and autoimmune diseases.  The company was acquired by Quidel (NASDAQ: QDEL) in January 2010.

Description: C:\Users\Danny Kwong\Desktop\images\epitomics.gif

Epitomics, Inc.
www.epitomics.com
South San Francisco, California
Epitomics, Inc., an emerging biotechnology company, is dedicated to developing proprietary Rabbit  monoclonal antibody technology (MAb) to the research and the therapeutic markets.  Its Rabbit monoclonal technology is considered the pioneer in the monoclonal antibody area and is becoming increasingly popular among end-users.  The Company was acquired by Abcam PIc (London: ABC) in April 2012.

Description: C:\Users\Danny Kwong\Desktop\images\Fermentas.jpg

 

 

 

 

 

 

 

 

 

Fermentas, Inc.
www.fermentas.com
Burlington, Onterio, Canada
Fermentas is a leader in the discovery, manufacturing, and marketing of high quality molecular biology products for life sciences research community worldwide. Product offerings include FastDigest restriction enzymes, DNA/RNA modifying enzymes, DNA/protein purification kits, reagents for use in PCR, cloning, and sequencing, etc.  The company was acquired by Thermo Fisher Scientific (NYSE: TMO) in May 2010.

 

Genewiz

http://www.genewiz.com/

South Plainfield, New Jersey

GENEWIZ is a leading global genomics service company. A full-service provider, GENEWIZ provides DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory services.  Excelling in both science and customer support, GENEWIZ is dedicated to accelerating scientific discovery, as well as to developing and delivering innovative solutions for translational medicine and healthcare.

 

Description: C:\Users\Danny Kwong\Desktop\images\optimer.gif

Optimer
www.optimerpharma.com
San Diego, California
Optimer (NASDAQ: OPTR) is developing novel carbohydrate chemistry to attack antibiotics-resistant bacteria.  Currently, the company has 2 proprietary antibiotics under late stage of clinical trials.  The company went public in February 2007.

Description: C:\Users\Danny Kwong\Desktop\images\panomics.gif

Panomics
www.panomics.com
Fremont, California
Panomics is developing and marketing novel and innovative tools for the molecular and cell biology research fields.  Panomics has merged with Genospectra in 2006 forming a new entity.  The new company currently operates under the name Panomics. The new company was acquired by Affymetrix (NASDAQ: Affx) in December 2008.

Description: C:\Users\Danny Kwong\Desktop\images\stemcyte.gif

StemCyte
www.stemcyte.com
Acadia, California
StemCyte specializes in cord blood stem cell technology including transplantation therapy, diagnostics, and research.

Description: C:\Users\Danny Kwong\Desktop\images\superarray.gif

SuperArray Biosciences
www.superarray.com
Frederick, Maryland
SuperArray, Inc. is a fast-growing company dedicated to providing life scientists and biomedical researchers with cutting edge array technology and a number of innovative research tools to advance functional studies. The company was acquired by Qiagen (NASDAQ: QGEN) in December 2009.

Description: C:\Users\Danny Kwong\Desktop\images\sbi.gif

 

 

 

 

 

 

 

 

 

System Biosciences
www.systembio.com
Mountain View, California
System Biosciences focuses on developing unique and proprietary siRNA and microRNA technologies that provide life science researchers with tools to investigate gene functions.

 

 

TP Therapeutics

http://www.tptherapeutics.com/

San Diego, California

TP Therapeutics, Inc. (TP) is a structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. 

Home | Company | News | Investment | Portfolio | Contact

 Copyright © 1999-2016, Kenson Ventures, LLC.  All rights reserved.